224 related articles for article (PubMed ID: 72074)
1. Altered metabolism of androgens in elderly men with benign prostatic hyperplasia.
Ishimaru T; Pages L; Horton R
J Clin Endocrinol Metab; 1977 Oct; 45(4):695-701. PubMed ID: 72074
[TBL] [Abstract][Full Text] [Related]
2. Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.
Morimoto I; Edmiston A; Horton R
J Clin Invest; 1980 Sep; 66(3):612-5. PubMed ID: 6156957
[TBL] [Abstract][Full Text] [Related]
3. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
[TBL] [Abstract][Full Text] [Related]
4. Dihydrotestosterone accumulation in genital skin fibroblasts derived from elderly men with prostatic hyperplasia.
Morimoto I; Eto S; Inoue S; Izumi M; Hara T; Saito Y; Nagataki S
J Clin Endocrinol Metab; 1992 Aug; 75(2):632-5. PubMed ID: 1379259
[TBL] [Abstract][Full Text] [Related]
5. In vivo uptake and metabolism of 3-h-5alpha-androstane-3alpha,17beta-diol and of 3-h-5alpha-androstane-3beta,17beta-diol by human prostatic hypertrophy.
Horst HJ; Dennis M; Kaufmann J; Voigt KD
Acta Endocrinol (Copenh); 1975 Jun; 79(2):394-402. PubMed ID: 49141
[TBL] [Abstract][Full Text] [Related]
6. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
Ghanadian R; Puah CM
J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
[TBL] [Abstract][Full Text] [Related]
7. The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-alpha-androstanediols.
Mahoudeau JA; Bardin CW; Lipsett MB
J Clin Invest; 1971 Jun; 50(6):1338-44. PubMed ID: 5103749
[TBL] [Abstract][Full Text] [Related]
8. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
9. Tissue androgen concentrations in golden hamsters with benign prostatic tumours.
Finney RW; Harper ME; Gaskell SJ; Griffiths K
J Endocrinol; 1980 Mar; 84(3):353-61. PubMed ID: 6156223
[TBL] [Abstract][Full Text] [Related]
10. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
11. Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate.
Geller J; Albert J; Lopez D; Geller S; Niwayama G
J Clin Endocrinol Metab; 1976 Sep; 43(3):686-8. PubMed ID: 60347
[TBL] [Abstract][Full Text] [Related]
12. The source of plasma dihydrotestosterone in man.
Ito T; Horton R
J Clin Invest; 1971 Aug; 50(8):1621-7. PubMed ID: 5097569
[TBL] [Abstract][Full Text] [Related]
13. Comparison of testosterone, 5alpha-dihydrotestosterone and 5alpha-adrostane-3beta, 17beta-diol metabolisms in human normal and hyperplastic prostates.
Morfin RF; Di Stefano S; Bercovici JP; Floch HH
J Steroid Biochem; 1978 Mar; 9(3):245-52. PubMed ID: 77360
[No Abstract] [Full Text] [Related]
14. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.
Hammond GL
J Endocrinol; 1978 Jul; 78(1):7-19. PubMed ID: 79632
[TBL] [Abstract][Full Text] [Related]
15. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
16. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Stanczyk FZ; Azen CG; Pike MC
J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
[TBL] [Abstract][Full Text] [Related]
17. Metabolic clearance rate and blood production rate of testosterone and dihydrotestosterone in normal subjects, during pregnancy, and in hyperthyroidism.
Saez JM; Forest MG; Morera AM; Bertrand J
J Clin Invest; 1972 May; 51(5):1226-34. PubMed ID: 5020435
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of testosterone, 5alpha-androstan-17beta-ol-3-one, 5alpha-androstane-3alpha,17beta-diol and 5alpha-androstane-3beta,17beta-diol in plasma of adult male rabbits by radioimmunoassay(1).
Schanbacher BD; Ewing LL
Endocrinology; 1975 Oct; 97(4):787-92. PubMed ID: 1193006
[TBL] [Abstract][Full Text] [Related]
19. Splanchnic extraction and conversion of testosterone and dihydrotestosterone in man.
Ishimaru T; Edmiston WA; Pages L; Horton R
J Clin Endocrinol Metab; 1978 Apr; 46(4):528-33. PubMed ID: 755039
[TBL] [Abstract][Full Text] [Related]
20. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]